2024 International Congress Archives - Page 74 of 181

Ibudilast, a Phosphodiesterase Inhibitor, Alleviates Huntington’s Disease Pathology through Neuroinflammation Modulation and Signaling Pathway Regulation in a Rat Model

S. -, V. Parcha (Dehardun, India)
Identification and Screening of Candidate Genes for Paroxysmal Movement Disorders by Next Generation Sequencing Approach for Developing Molecular Diagnostics.

P. S, R. Sampath, P. L K, V. Gowda, A. Kolandaswamy (Bangalore, India)
Identification of Allosteric GCase Correctors Using Revenir™ for the Treatment of GBA1-Parkinson’s Disease

J. Dupaul-Chicoine, S. Lavallée, N. Azevedo Portilho, L. Gong, M. Fournel, I. Ghosh, MR. Goldsmith, M. Ebert, O. Rousseau, L. Fader, JF. Marquis, S. Hedge (Saint-Laurent, Canada)
Identification of Brain Atrophy Subtypes in Prodromal and Overt Synucleinopathies: A Multicenter Study

S. Joza, A. Delva, C. Tremblay, A. Vo, J-F. Gagnon, R. Postuma, P. Dusek, M. Hu, J. Klein, J-P. Taylor, J. O'Brien, M. Firbank, A. Thomas, P. Donaghy, S. Lehericy, I. Arnulf, M. Vidailhet, J-C. Corvol, M. Sommerauer, S. Röttgen, S. Lewis, E. Matar, K. Ehgoetz Martens, L. Churchill, R. Camicioli, H. Chertkow, P. Borghammer, K. Knudsen, A. Hansen, D. Arnaldi, B. Orso, P. Matiioli, A. Dagher, S. Rahayel (Montreal, Canada)
Identification of Compound Heterozygous and Novel Deep-Intronic TH Mutations in a Chinese Patient with Dopa-Responsive Dystonia

XS. Zheng (Hangzhou, China)
Identification of Fall Risk in Patients with Parkinson’s Disease Through Telemonitoring

F. Kanellos, G. Rigas, A. Ntanis, N. Kostikis, S. Kontaxis, L. Liouta, C. Tsitsou, S. Konitsiotis (Ioannina, Greece)
Identification of Novel Blood Biomarkers among Data-Driven Parkinson’s Disease Clusters in Asian Populations

X. Dneg, L. Tan, E. Tan, A. Ng, J. Tan (Singapore, Singapore)
Identification of Pre-Diagnostic Biomarkers for Parkinson’s Disease from Plasma Proteome

M. Ta, E. Appleton, S. Khosousi, A. Sturchio, I. Markaki, W. Paslawski, C. Blauwendraat, M. Nalls, A. Singleton, P. Svenningsson, H. Iwaki (Bethesda, USA)
Identification of underlying Lewy body pathology in primary tauopathies by α-synuclein seed amplification assay

L. Concha-Marambio, C. Farris, S. Weber, Y. Ma, T. Tropea, D. Irwin, A. Siderowf, B. Mollenhauer (san diego, USA)
Identifying and Managing Spasticity in Neurological Shoulder Dysfunction

D. Hoad, S. Ashford, G. Bavikatte, R. Farrell, A. Robertson, J. Wissel (Coventry, United Kingdom)
Identifying Barriers and Facilitators to Accessing Care for Members of the Black Diaspora and Hispanic People Affected by Parkinson Disease: A Qualitative Study

D. Kipnis, M. Lin, A. Pacheco, N. Mensah, Y. Gu, C. Macpherson, K. Kempner, A. Parker, RB. Coley, D. Coley, H. Shah, L. Quinn (New York, USA)
Identifying key symptoms associated to parkinsonism other than Parkinson’s Disease: a case series

M. Gaitan-Palau, C. Armengol-Garcia, D. Martinez-Ramirez (Monterrey, Mexico)
Identifying Subjects with Dopamine Transporter Deficit in a Population-based Recruitment Strategy: Kassel Data of Healthy Brain Ageing

S. Schade, K. Rege, C. Corinne, A. Garrido, T. Marques, P. Mahlknecht, S. Ghosh, R. Rawal, C. Pauly, T. Wicke, E. Lang, S. Schnell, S. Scaglione, H. Hakelberg, V. Satagopam, M. Marti, E. Tolosa, W. Poewe, R. Krüger, C. Trenkwalder, B. Mollenhauer, D. Pilco (Kassel, Germany)
Identifying the Most Sensitive Patient-reported Items from the MDS-UPDRS that Predict Initiation of PD Medications in Early Disease

H. Zou, C. Goetz, G. Stebbins, T. Mestre, S. Luo (Durham, USA)
Idiopathic Parkinson’s disease and Normal pressure Hydrocephalus – a tale of two sisters

P. Vvsrk, S. Kola, R. Alugolu, R. Kandadani, R. Borgohain (Hyderabad, India)
If Oral Levodopa is not Possible, Keep Calm and Breathe Deeply

D. García-Meléndez, E. Gisbert Tijeras, B. Carmona Moreno, E. Botia Paniagua (Alcázar San Juan, Spain)
IGF2 Induce Neuroprotection in PD Preclinical Models by Modulation of Immune Response.

FG. Grünenwald, MC. Cisternas, DS. Sepulveda, TH. Huerta, CJ. Jerez, RP. Pacheco, RLV. Vidal (Santiago, Chile)
ilex Paraguariensis (Yerba mate) modulates the AMPK pathway and downstream key metabolic mechanism that may explain its neuroprotective role.

J. Ferrario, H. Hauche, L. Tschopp, T. Eidelman, M. Bordone (Buenos Aires, Argentina)
Image-guided Programming versus Conventional Programming in Deep Brain Stimulation: Comparative Study of a Parkinson’s Disease Cohort and Subthalamic Neurostimulation

A. Neves, L. Sousa, M. Rito, C. Chamadoira, J. Massano, M. Rosas, C. Soares (Porto, Portugal)
Imaging the Nigrostriatal Pathway in Patients with Idiopathic Normal Pressure Hydrocephalus and Parkinsonism

G. Palermo, A. Francesconi, G. Bellini, R. Morganti, G. Migaleddu, D. Di Carlo, P. Perrini, N. Benedetto, C. Pacchetti, D. Volterrani, M. Cosottini, R. Ceravolo (Pisa, Italy)
Imaging-based Troubleshooting Deep Brain Stimulation in Parkinson’s Disease

J. Yamamoto, I. Paraguay, R. Barbosa, E. Barbosa, R. Cury (Sao Paulo, Brazil)
Immune cell traits and Parkinson’s disease: A Mendelian randomization study

JL. Wang, Y. Fang, YL. Li, R. Zheng, Y. Chen, J. Tian, XZ. Yin, JL. Pu, BR. Zhang (Hangzhou, China)
Immunomodulatory Effects Of Covid-19 Vaccination On Inflammatory And Neurotrophic Factors In Parkinson’s Disease: Insights From Clinical Subtypes

J. Salimjonov, N. Rashidova, KH. Khalimova, R. Matmurodov (Tashkent, Uzbekistan)
Immunoproteasome subunits as emerging contributors to neurodegeneration in Parkinson’s Disease

HD. Nguyen, YE. Kim (Anyang-si, Gyeonggi-do, Republic of Korea)
Impact of 24-hour Subcutaneous Levodopa/Carbidopa Infusion (ND0612) on Motor State Transitions Throughout the Day

A. Ellenbogen, J. Ferreira, F. Stocchi, K. Kieburtz, A. Albanese, L. Adar, N. Vostokova, J. Pereira, R. Hauser (Farmington Hills, USA)
Impact of Altered Cerebrovascular Reactivity on Midbrain Degeneration, Perfusion and White Matter

N. Hoffman, S. Nitschke, K. Julio, N. Shaff, A. Dodd, G. Suarez Cedeno, A. Deligtisch, D. Sugar, E. Erhardt, H. Lin, A. Vakhtin, H. Van-Der-Horn, S. Pirio Richardson, A. Mayer, S. Ryman (Albuquerque, USA)
Impact of Cognitive Impairment on Mobility and Linguistic Metrics During a Dual-task in PD

K. Smith, D. Martini (Worcester, USA)
Impact of Community Boxing Program on Non-motor Symptoms in Individuals with Parkinson’s Disease

M. Braitsch, S. Shearin, R. Querry, E. Perez (Richardson, USA)
Impact of DBS STN on motor symptoms, postural instability, QoL in PD patients from the Belarusian population

A. Buniak, S. Likhachev, V. Alexeyevets, V. Bayarchyk (Minsk, Belarus)
Impact of IPX203 on Parkinson’s patients’ motor states upon awakening: analysis of patient diary data

S. Isaacson, H. Fernandez, C. Kilbane, G. Banisadr, A. Pitman, S. Fisher, R. D'Souza (Boca Raton, USA)
Impact of Patient Input on the Study Execution of a Prospective, Epidemiological Study

R. Zorowitz, L. Barrenechea, S. Butet, S. Groppa, D. Herrero, R. Prasad, S. Sandars, P. Maisonobe, S. Page, A. Picelli (Washington, USA)
Impact of Prior Head Trauma on Parkinson’s Disease Experience

S. Vallamkonda, A. Hohler (Boston, USA)
Impact of Striatal Degeneration on Clinical Phenotype in Idiopathic Normal Pressure Hydrocephalus: A Comparative Analysis

K. Badiola-Lim, Q. Hu, N. Prakash (Summit, USA)
Impact of Striatal Degeneration on Patient Reported Symptoms in Idiopathic Normal Pressure Hydrocephalus

Q. Hu, K. Badiola-Lim, D. Karimeddini, C-L. Kuo, N. Prakash (Farmington, USA)
Impact of sub-acute MPTP exposure on the cerebellum in adult male Balb/c mice

F. Sulaimon, R. Ibiyeye, R. Adeniyi, Y. Jimoh, M. Awodola, T. Adeoye, M. Shehu (Ilorin, Nigeria)
Impact of Surrounding Audio-Visual Complexity on Symptomatology of Laryngeal Dystonia: A Virtual Reality Study

J. Petit, S. Ehrlich, G. Tougas, J. Bernstein, N. Buie, K. Simonyan (Boston, USA)
Impact of Temperature Variation on Emergency Department Visits for Parkinson’s Disease Patients Amongst Two Sites

S. Vallamkonda, D. Petrosyan, B. Westbrook, N. Kakos, C. Hinds, R. Adlis, A. Menta, J. Lowry, D. Brooks, O. Hofheinz, P. Bhaya, J. Kong, M. Muppirala, A. Benchouia, A. Fajayan, A. Hohler, E. Vaou (Boston, USA)
Impact on quality of life and nonmotor symptoms of unilateral magnetic resonance-guided focused ultrasounds (FUS) thalamotomy in patients with essential tremor.

D. Vilas, L. Ispierto, M. Tardáguila, J. Muñoz, A. González, M. Gea, JA. Pérez, R. García-Yuste, R. álvarez (Badalona, Spain)
Impairment of REM Sleep Architecture: A Potential Biomarker for Parkinson’s Progression

A. Mirzazadeh, R. Levy, H. Rahul, R. Dorsey, A. Videnovic, D. Katabi (Cambridge, USA)
Implementation of the Parkinson’s Disease-Health Index (PD-HI), a Novel, Validated, Disease-Specific Patient-Reported Outcome Measure, in a 24-Month Natural History Study

J. Purks, J. Seabury, J. Weinstein, A. Varma, S. Rosero, C. Engebrecht, C. Irwin, C. Shupe, A. Arky, J. Heatwole, C. Zizzi, N. Dilek, J. Adams, E. Dorsey, C. Heatwole (Rochester, USA)
Implications of BSCL2 Mutation in the Pathogenesis of Parkinson’s Disease

AY. Regalado-Mustafá, CF. álvarez-Hernandez, WF. Moguel-Cardin, AL. Guerra-Anzaldo, A. Domínguez-García, MAG. Medrano-Delgado, AJ. Hernández-Medrano, A. Cervantes-Arriaga, A. Abundes-Corona, A. Guevara-Salinas, M. Rodríguez-Violante, N. Monroy-Jaramillo, LV. Adalid-Peralta (Mexico City, Mexico)
Improved Quantification of DAT-SPECT significantly increases its Performance as an Imaging Biomarker in Parkinson’s Disease

R. Gunn, Z. Fan, D. Russell, J. Eberling, K. Marek, J. Seibyl, FOR. Ppmi (London, United Kingdom)
Improvement in Uninterrupted Good ON Time and Reduction in OFF Periods with CSAI Treatment

D. Kremens, R. Hauser, A. Formella, M. Joshi, M. Grall (Philadelphia, USA)
Improvement in upper limb spasticity patterns in the elderly following treatment with incobotulinumtoxinA: a pooled analysis

M. Munin, A. Camões-Barbosa, C. Cordero-García, M. Althaus, G. Comes, M. Vacchelli, C. Walter, J. Wissel (Pittsburgh, USA)
Improvement in Upright Stability subscale of mFARS with Vatiquinone Treatment in MOVE-FA: a Phase 3, Double-blind, Placebo-controlled Trial

D. Lynch, A. Duquette, M. França Jr, S. Perlman, A. Durr, E. Bertini, A. Darling, K. Mathews, L. Schöls, A. Fournier, M. Delatycki, S. Subramony, R. Roxburgh, O. Zhang, C. Rummey, A. Salvucci, B. Yao, J. Cherry, L. Golden, T. Zesiewicz (Philadelphia, USA)
Improving awareness of motor fluctuations in Parkinson’s Disease: an educational patient support program using a waist-worn device.

N. Caballol, A. ávila, A. Planas-Ballvé, A. Peral, J. Hernández-Vara, S. Belmonte, S. Enríquez, S. Sánchez, D. Cerdán, I. Cabo, N. López-Ariztegui, G. Carvalho, JM. Velázquez, T. Delgado, J. Bocos, B. Ruiz, B. Claramonte, J. Herreros-Rodríguez, D. Santos-García, C. Cores-Bartolomé, J. González-Ardura, D. Ceberino, JM. Salom, R. Rashid, A. Méndez, C. Madrid-Navarro, A. Mulet, D. Rodríguez-Martín, I. Pijuan, I. Tegel (Sant Joan Despí, Spain)
Improving Neuropsychiatric Comorbidity in Geriatric Spinocerebellar Ataxia

M. Le, B. Carr (Gainesville, USA)
Improving Work Up amongst Patients with Rare Movement Disorders according to Diagnostic Yield Findings– Update from Single Center Neurogenetic Clinic

D. Penn, Y. Amir, G. Ben David, J. Zitser Koren, G. Gurevich, H. Baris Feldman, R. Alcalay, Y. Yaron, P. Ponger (Tel Aviv, Israel)
In Silico Electrophysiology and System Pharmacology Reveal Coupling Between Dopamine Receptors and Ca2+ Channels in Subthalamic Neuronal Cells towards Parkinson’s Disease

C. Mahapatra (Mumbai, India)
Incidence and Prevalence of Parkinson’s Disease Among United States Medicare Beneficiaries by Age, Sex, Race/Ethnicity, and Neighborhood Socioeconomic Status 2014-2021

T. Rosa, S. Mantri, C. Ford, S. Soneji, B. Kaufman, F. Li, B. Grory, Y. Xian, K. Johnson, R. O’Brien, E. O’Brien, J. Lusk, B. Hammill (Durham, USA)
Incidence of Depression in the Caregivers of Parkinson’s Disease Patients

S. Soleimani, M. Salari, F. Hojjati Pour (Tehran, Islamic Republic of Iran)
Incident & Prevalent Dementia in Individuals with Parkinson’s Disease in the Framingham Heart Study

J. Dookhy, Y. Li, A. Gurnani, S. O'Shea, S. Frank, R. Au, J. Mez, Y. Liu, TFA. Ang, L. Shih (Galway, Ireland)
Inclusion of PSP-Parkinsonism (PSP-P) phenotype in clinical trials – power calculation

N. Olfati, S. Akhlaghi, A. Shoeibi, I. Litvan (San Diego, USA)
Incobotulinumtoxin A to Treat Sialorrhea in Parkinson’s Disease: a Real-life Study: 5-year Interim Results

B. Bergmans, N. Winter, V. Schotte, N. Sys, E. van Massenhove, G. Pollet, H. Couckuyt, L. Delameilleure, M. van Zandijcke (Bruges, Belgium)
Incorporating the Voice of the Patient and Caregiver into a Multiple System Atrophy (MSA) clinical trial

J. Marer, G. Krog, D. Houghton, J. Nettleship, M. Chen, L. Marinelli (Netanya, Israel)
Increased alpha-internexin levels are associated with a higher risk of Parkinson’s disease

X. Guo, G. Tian, R. Zhou, R. Li (Xi'an, China)
Increased Brain Free Water is Associated with Regional Gene Expression in Parkinson’s Disease

D. Zhang, J. Yao, H. He, T. Wu (Beijing, China)
Increased Brain-Age Gap Estimate (BrainAGE) in Neurological Wilson Disease

A. Hausmann, J. Caspers, S. Kannenberg, S. More, K. Patil, A. Schnitzler, C. Rubbert, C. Hartmann (Duesseldorf, Germany)
Increased cerebellar grey matter in writer’s cramp patients: a morphometric signature of symptom compensation

K. Witt, V. Yogeswaran, J. Stalter, A. Knutzen, A. Baumann, K. Zeuner (Oldenburg, Germany)
Increased cholinergic activity in specific brain regions associated with the presence of dyskinesias in Parkinson’s disease: A [18F]-FEOBV PET study

N. Bohnen, G. Carli, F. Michalakis, C. Pongmala, M. Emde Boas, R. Albin, P. Kanel (Ann Arbor, USA)
Increased Resting Anterior Hippocampus Metabolism and Hippocampus Subfields Structural Abnormalities in Functional Tremor Patients: FDG- PET Study and Volumetric MRI Study

M. Ahmed, P. Dupont, S. Du Plessis, J. Warwick, A. Doruyter, E. Lee Pan, J. Carr (Cape Town, South Africa)
Increased Risk of Suicidal Ideation in Patients with Spinocerebellar Ataxias

C. Lin, L. Peppel, R. Lai, C. Rummey, P. Opal, J. Schmahmann, C. Gomez, H. Paulson, T. Zesiewicz, S. Perlman, G. Wilmot, S. Ying, C. Onyike, K. Bushara, M. Geschwind, K. Figueroa, S. Pulst, S. Subramony, A. Duquette, T. Ashizawa, A. Hamedani, M. Davis, S. Srinivasan, M. Burns, L. Moore, V. Shakkottai, L. Rosenthal, S. Kuo (Houston, USA)
Increasing access to Deep Brain Stimulation for an underserved patient population: A retrospective cohort from an urban hospital in a diverse county in the USA.

Y. Xu, J. Acquaviva, A. Castillo, B. Puccio, E. Feinstein (Newark, USA)
Increasing diagnostic accuracy of Multiple System Atrophy – A Videolibrary on clinical and imaging features

V. Sidoroff, A. Antonini, A. Batla, N. Bendahan, G. Calandra Buonaura, N. Campese, G. da Prat, M. Fabbri, A. Fanciulli, J. Ferreira, F. Gandor, D. Goldstein, T. Gurevich, S. Katzdobler, H. Kaufmann, J. Klempir, V. Kostic, F. Krismer, V. Khurana, A. Lang, J. Levin, N. Mcfarland, P. Millar Vernetti, M. Pellecchia, I. Petrovic, W. Poewe, N. Quinn, C. Raccagni, R. Moiron Simões, W. Singer, M. Michael Strupp, M. Stamelou, G. Höglinger, G. Wenning, I. Stankovic (Innsbruck, Austria)
Indentifying Key Features for Predicting Clinical Status in Huntington’s Disease Patients Using Raw Speech Samples: a Lightweight Machine Learning Approach

T. Le Ludec, C. Le Moine, A-C. Bachoud-Lévi, R. Massart (Creteil, France)
Indications of advanced therapies in Parkinson’s Disease: a retrospective study in a Belgian reference center

B. Delsaut, V. Leclercq, S. Dethy (La Louvière, Belgium)
Inflammation Biomarkers and Free Water Fraction in the Cholinergic Forebrain System in Idiopathic Parkinson’s Disease

S. Crowley, P. Kanel, S. Roytman, B. Hampstead, N. Bohnen (Charelston, USA)
Influence of Fatigue in Parkinson’s Disease on Variability of Gait Measures

I. Sierra, S. Perfetto, A. Potvin-Desrochers, C. Mvomo, J. Bedime, H. Lajeunesse, F. Parent-L'Ecuye, C. Paquette (Montreal, Canada)
Influence of immigration on Parkinson’s disease: analysis of clinical presentation.

A. Peral Quirós, N. Caballol Pons, A. Planas Ballvé, M. Balagué Marmaña, MI. Gómez Ruiz, A. ávila Rivera (Barcelona, Spain)
Influence of the Level of Education on the Change in Cognitive Function in Parkinson´s Disease. A 5-year Follow-up Study.

D. Santos García, T. de Deus, C. Cores, M. íñiguez, L. Samaniego, J. Paz González, S. Jesús, M. Cosgaya, J. García Caldentey, N. Caballol, I. Legarda, I. Hernández Vara, I. Cabo, L. López Manzanares, I. González Aramburu, M. Avila, V. Gómez Mayordomo, V. Nogueira, J. Dotor, C. Borrué, B. Solano, M. álvarez Sauco, L. Vela, S. Escalante, E. Cubo, Z. Mendoza, J. Martínez Castrillo, P. Sánchez Alonso, G. Alonso Losada, N. López Ariztegui, I. Gastón, J. Kulisevsky, M. Seijo, C. Valero, R. Alonso Redondo, T. Buongiorno, C. Ordás, P. Martínez Martín, P. Mir, S. Coppadis (A Coruña, Spain)
Initial Results After Launch of Best Practice Advisory for Contraindicated Agents in Parkinson’s Disease and Related disorders

N. Shah, N. Chunga, K. Amodeo, I. Richard (Rochester, USA)
Initiating a Hybrid-Modality International Movement Disorders Fellowship: A Collaborative Effort Among Latin American Countries

P. Salles, S. Peña, S. Silva, R. Jauregui, P. Saffie, P. Chaná-Cuevas (Santiago de Chile, Chile)
Initiation of AT-HOME PD2, a Remote Observational Study of Parkinson’s Disease Clinical Trial Participants

R. Schneider, A. Hoyt, R. Wilson, S. Mahes, C. Stevens, C. Tarolli, J. Adams, B. Valdovinos, K. Lizarraga, P. Auinger, S. Benvengo, M. Monje, E. Macklin, D. Weintraub, K. Biglan, A. Ascherio, A. Espay, C. Tanner, D. Novak, J. Beck, I. Shoulson, T. Simuni, S. Sieberts, E. Dorsey, M. Schwarzschild (Rochester, USA)
Instrument-supported Gait Analysis Characterizes Gait Domain Changes in Patients with Suspected Normal Pressure Hydrocephalus – a Retrospective Study

C. Semmler (Cologne, Germany)
Insulin-like growth factor 2 and inflammatory response in Parkinson Disease: Potential predictor marker

CA. Aguilera, FG. Grünenwald, VU. Urbina, EL. Larraechea, RLV. Vidal (Santiago, Chile)
Integrated Clinical Research Intern Program: Impact Upon Recruitment of Participants for Therapeutic Studies Aimed at Parkinson’s Disease (PD) Prevention.

L. Lemon, A. Faraday, J. Nevins, M. Nygard, M. Mcmahon (Cincinnati, USA)
Integrated management of persons with Parkinsonism: a new model of patient-centered healthcare at home coordinated by a Case Manager via Telenursing.

R. Cilia, C. Leuzzi, M. Catotti, J. Cordasco, C. Moreschi, R. Eleopra (Milano, Italy)
Integrating Non-Motor Symptoms and Gender Variability in Machine Learning for Early Parkinson’s Disease Detection

MZA. Ali, PSD. Dholaniya (Hyderabad, India)
Integrating Parkinson’s Plus Cohorts into the Global Parkinson’s Genetics Program

D. Vaughan, M. Theilmann Jensen, O. Serrano Asensio, T. Tharmaraja, S. Jasaityte, E. Stafford, H. Houlden, A. Huey Tan, S. Lim, H. Morris, GP2. Genetics Program (London, United Kingdom)
Intelligent Assessment of Abnormal Movements in Neurological Disorders: An Update

YJ. Bao, RH. Hong, WT. Qin, Z. Wu, YP. Song, LJ. Jin (Shanghai, China)
Intensive Neurophysiological Rehabilitation System As a New Approach for Treatment of ASD Children

T. Voloshyn (lviv, Ukraine)
Inter- and intra-day variability in β-Glucocerebrosidase activity and pathway biomarkers in healthy volunteers and patients with Parkinson’s disease with a GBA1 mutation

J. Vandervalk, D. Dumas, E. Thijssen, D. Pereira, W. Grievink, Y. Yavuz, C. Pesch, D. Ysselstein, M. Hagey, J. Cedarbaum, K. Hunt, P. Kremer (Leiden, Netherlands)
Interaction of GCase and ganglioside GM1 in the aggregation of α-Synuclein

F. Fierli, G. Uras, S. Lucas-Del Pozo, S. Koletsi, V. Lentini, M. Toffoli, P. Caboni, A. Schapira (London, United Kingdom)
Interim Analysis of the Feasibility of Mediterranean-Ketogenic Dietary Interventions in Parkinson’s Disease

K. Tosefsky, Y. Wang, A. Kuan, V. Ngo, C. Agu, D. Liang, L. Liu, O. Geiger, S. Keymanesh, M. Sacheli, E. Gerson, S. Cresswell (Vancouver, Canada)
Interim Report of Quality of Life Outcomes After Deep Brain Stimulation for Parkinson’s Disease from a Large Global Real-World Study

A. Gharabaghi, L. Lopez, A. Schnitzler, S. Chen, L. Himes, M. Frassica, D. Nanduri, S. Groppa (Tuebingen, Germany)
Interim results of a mixed method research-in-action study to evaluate and improve patient and public involvement within the EJS ACT-PD initiative

M-L. Zeissler, N. Lapelle, S. Collins, E. Cowd, C. Gonzalez-Robles, R. Ellis-Doyle, G. Mills, R. Petty, T. Foltynie, C. Carroll, K. Mcfarthing (Plymouth, United Kingdom)
Intermediate Expansion of MARCHF6 causes FAME3 without Epilepsy

C. Del Gamba, E. Bieth, S. Kaya, E. Leitão, K. Astudillo, S. Frucht, C. Depienne, G. Riboldi (New York City, USA)
International Perspectives of Care Partners for People with Parkinson’s Disease

R. Herlihy, E. Trahair, A. Allen, A. Gonzalez, K. Hill, L. Kapust, A. Kosem, J. Mckenzie, E. Book (Albany, USA)
Intraepidermal Nerve Fiber Density at Baseline Associates with One-year Clinical Disease Progression in Multiple System Atrophy

M. Andréasson, P. Karlsson, K. Samuelsson, P. Svenningsson (Stockholm, Sweden)
Intrafamilial phenotypic variability of DYT-ANO3: Analyzing 14 affected members with a novel variant

J. Ganguly, N. Sarmah, A. Rawool, H. Kumar (Kolkata, India)
Intraoperative venous air embolism in the semi-sitting position in functional neurosurgery

J. Runge, A. Abdulbaki, A. Saryyeva, JK. Krauss (Hannover, Germany)
Intraventricular baclofen and bilateral pallidotomy in a pediatric patient with acquired generalized dystonia and refractory status dystonicus

O,. Escobar, S. Ordóñez-Cure, J. Arias-Angulo, L. Ortega-Bolaños, V. Martínez-Villota (Cali, Colombia)
Intrinsic Auricular Muscle Zone Stimulation for Moderate-to-Severe Parkinson’s Disease

S. Brillman, A. Samiian, V. Sharma, S. Ertan, . öztop çakmak (Palo Alto, USA)
Investigating an Emerging Anxiety-like Phenotype in a Novel Bilateral Rodent Model of Parkinsonian Alpha-Synuclein Pathology

N. Lipari, I. Sandoval, F. Manfredsson, C. Bishop (Binghamton, USA)
Investigating Cognitive Impairments in early Parkinson’s disease

K. Patel, K. van Hedger, S. Pasternak, P. Macdonald (London, Canada)
Investigating Copy Number Variations in SNCA and PRKN in a Cohort of Kazakhstani Patients with Parkinson’s Disease and Healthy Controls

R. Kaiyrzhanov, N. Zharkynbekova, S. Abdraimova, C. Shashkin, Z. Myrzayev, A. Karimova, V. Akhmetzhanov, K. Mok, J. Hardy, H. Houlden (Shyment, Kazakhstan)
Investigating Impaired Perceptual Decision Making in Cervical Dystonia: A novel paradigm integrating Behavioural and Neural measures

K. Miyauchi, M. Lakhotiya, A. Gill, S. Rafee, C. Fearon, R. Reilly (Dublin, Ireland)
Investigating Interrater Reliability of the Unified Huntington’s Disease Rating Scale Motor Component Between Learner and Experienced Rater

M. Janz, W. Adams, A. Key, R. Zschiegner, D. Burks, K. Shannon, J. Paulsen (Madison, USA)
Investigating the genetic relationship between vitamin B12 deficiency and Parkinson’s disease

K. Senkevich, R. Dering, M. Onvumere, L. Liu, P. Huot, Z. Gan-Or (Montreal, Canada)
Investigating the pathogenesis of GBA1-associated Parkinson’s disease using GBA1 isogenic iPSC lines

Y. Chen, C. Chen, C. Ma, J. Lichtenberg, E. Hertz, T. Jong, R. Sam, Y. Li, S. Vrisjen, P. Vangheluwe, C. Blauwendraat, E. Sidransky (Bethesda, USA)
Investigating the Use of 18F-DOPA PET/CT to Improve Diagnosis and Clinical Management of Parkinson’s Disease in South Australian Movement Disorder Clinics.

D. Sharma, M. Nottage, W. Vallat, R. Wilcox, M. Tan, N. Liam, A. Dwyer (Adelaide, Australia)
Investigation of the Beta Oscillations of Local Field Potential in the Subthalamic Nucleus of the Parkinsonian Minipig Model

HC. Lin, YH. Wu, FY. Liu, MD. Ker (Hsinchu, Taiwan)
Investigation of the Quantitative Impact of T-type Calcium Channels in Subthalamic Nucleus Neurons on Parkinson’s Disease

A. Pradhan, C. Mahapatra (Bengaluru, India)
Ionic Plasticity of Midbrain GABAergic Synapses in PD Models

A. Borgkvist, E. Bezard, M. Molinari, E. Santini, M. Canron (Solna, Sweden)
iPLA2β controls ER-mitochondria tethering and Ca2+ transfer in Parkinson’s disease

ZH. Lin, Y. Liu, NJ. Xue, BR. Zhang, JL. Pu (Hangzhou, China)
iPSC-Based Modeling of SCA12 for Targeted Therapeutic Screening

B. Reddy, A. Gerutshang, R. Roy, R. Banerjee, S. Chowdhury, H. Kumar, S. Chattarji (Kolkata, India)
IPSC-derived Cortical Neurons from Parkinson’s Patients with VPS35 Mutation show Defects in Synapto- and Neurogenesis

U. Scheller, CK. Lee, P. Seibler, M. Mitkovski, JS. Rhee, C. van Riesen (Goettingen, Germany)
Is acute dystonia in a teenager psychogenic dystonia?

G. Ilina, D. Khasanova, Z. Zalyalova, A. Lestrovaya (Kazan, Russian Federation)
Is cathepsin D a good target for therapy in Tau-related conditions?

G. Kovacs, A. Jafrani, G. Puska, I. Martinez-Valbuena, S. Lee, S. Knott, A. Karakani, S. Tanikawa, A. Lang, S. Forrest (Toronto, Canada)
Is essential tremor-plus phenotype a prodromal phase of Parkinson’s disease ?

A. Rekik, A. Mili, H. Slimene, K. Jemai, E. Jarrar, A. Hassine, S. Naija, S. Ben Amor (Sousse, Tunisia)
Is fatigue a rate limiting factor for achieving motor learning and functional gains in people with spinocerebellar ataxia? (PRIME-Ataxia RCT)

C. Macpherson, F. Awad, V. Rana, S. Kuo, L. Quinn (New York City, USA)
Is GPI DBS as effective to STN DBS for tremor control in Parkinson’s disease?

A. Prabhu, C. Reddy, K. Pillai, H. Chovatiya, M. Chacko, A. Avarachan, A. Kishore (Kochi, India)
Is Neuropsychological Evaluation Needed to Assess DBS Candidacy in Essential Tremor?

T. Turner, C. Cooper, F. Rodriguez-Porcel, D. Lench, V. Hinson, G. Revuelta (Charleston, USA)
Is the new device Percept-Medtronic really helping clinicians identifying location of contacts within the STN in STN-DBS?

M. Ruiz-Lopez, B. Tijero, T. Fernández, G. Bilbao, E. Ruizdegopegui (Barakaldo, Spain)
Is the sebum RNA transcriptome analysis technique capable of non-invasively diagnosing Parkinson’s disease?

T. Iseki, Y. Ueda, T. Kuwano, T. Inoue, S. Saiki, N. Hattori (Bunkyo-ku, Japan)
Istradefylline effects on L-Dopa resistant tremor in Parkinson’s disease

G. Ozay, I. Zhang, M. Umali, L. Lovelace, M. Barry, L. Ariza Serrano, A. Sharma, L. Raslan, Y. Torres-Yaghi, F. Pagan (Washington, USA)
Istradefylline therapy for dystonia in Parkinson’s disease

NAO. Kanzato, KOH. Nakachi, SAT. Mochizuki, (Okinawa, Japan)